These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37756486)

  • 21. Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
    Crown A; Rocha FG; Raghu P; Lin B; Funk G; Alseidi A; Hubka M; Rosales J; Lee M; Kennecke H
    J Surg Oncol; 2020 Mar; 121(3):480-485. PubMed ID: 31853990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. False-Positive 68 Ga-DOTATATE Uptake in a Uterine Subserosal Fibroid Mimicking Mesenteric Neuroendocrine Tumor : A Case Study.
    Khalaj K; Rowe JH; Thupili CR; Tammisetti VS
    Clin Nucl Med; 2023 Sep; 48(9):e452-e454. PubMed ID: 37482671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Utility of Total
    Tirosh A; Papadakis GZ; Millo C; Hammoud D; Sadowski SM; Herscovitch P; Pacak K; Marx SJ; Yang L; Nockel P; Shell J; Green P; Keutgen XM; Patel D; Nilubol N; Kebebew E
    Gastroenterology; 2018 Mar; 154(4):998-1008.e1. PubMed ID: 29155309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
    Etchebehere EC; de Oliveira Santos A; Gumz B; Vicente A; Hoff PG; Corradi G; Ichiki WA; de Almeida Filho JG; Cantoni S; Camargo EE; Costa FP
    J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Correlation Between [
    Yu J; Li N; Li J; Lu M; Leal JP; Tan H; Su H; Fan Y; Zhang Y; Zhao W; Zhu H; Pomper MG; Zhou Y; Yang Z
    Mol Imaging Biol; 2019 Oct; 21(5):984-990. PubMed ID: 30796708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synchronous Pancreatic Serous Cystic Neoplasm and Duodenal Neuroendocrine Tumor: Case Report and Review of the Literature.
    Madelung AB; Detlefsen S
    Int J Surg Pathol; 2018 Sep; 26(6):551-557. PubMed ID: 29623746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CT.
    Ulaner GA; Bodei L
    Clin Nucl Med; 2019 Apr; 44(4):330-331. PubMed ID: 30688738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-pancreatic Accessory Spleen Mimicking Pancreatic Neuroendocrine Tumor on 68-Ga-Dotatate PET/CT.
    Bostancı EB; Oter V; Okten S; Küçük NO; Soydal C; Turhan N; Akoglu M
    Arch Iran Med; 2016 Nov; 19(11):816-819. PubMed ID: 27845553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of
    Shell J; Tirosh A; Millo C; Sadowski SM; Assadipour Y; Green P; Patel D; Nilubol N; Kebebew E
    Eur J Radiol; 2019 Mar; 112():130-135. PubMed ID: 30777201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrocystic type of serous cystadenoma with a communication between the cyst and pancreatic duct.
    Hashimoto M; Watanabe G; Miura Y; Matsuda M; Takeuchi K; Mori M
    J Gastroenterol Hepatol; 2001 Jul; 16(7):836-8. PubMed ID: 11446898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic serous cystadenoma with signs of compression.
    Feldis M; Marty M; Dilly M; Laurent F; Chiche L; Cassinotto C
    Diagn Interv Imaging; 2013 Sep; 94(9):905-8. PubMed ID: 23791188
    [No Abstract]   [Full Text] [Related]  

  • 32. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
    Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
    Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic neuroendocrine tumor with serous cystadenoma: A rare entity.
    Zhang H; Lin Y; Shang Y; An P
    Asian J Surg; 2024 Sep; 47(9):3988-3990. PubMed ID: 38724359
    [No Abstract]   [Full Text] [Related]  

  • 34. Should
    Babazadeh NT; Schlund DJ; Cornelius T; Singh JS; Tierney JF; Chen M; Keutgen XM
    World J Surg; 2020 Feb; 44(2):604-611. PubMed ID: 31576440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F-FDG PET/CT and 68Ga-DOTATOC PET/CT in Diffuse Pancreatic Neuroendocrine Tumor.
    Ji X; Dong A; He Q; Dong H; Zuo C
    Clin Nucl Med; 2020 May; 45(5):e245-e248. PubMed ID: 32049733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obstructive Jaundice as a Complication of Macrocystic Serous Cystadenoma of the Pancreas.
    Koncoro H; Putra IK; Wibawa ID
    Acta Med Indones; 2016 Apr; 48(2):129-33. PubMed ID: 27550882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Detection of Hepatic Metastases on 68 Ga-DOTATATE PET/CT and 177 Lu-DOTATATE SPECT/CT.
    Zahed H; Beauregard JM; Abikhzer G; Rush C; Probst S
    Clin Nucl Med; 2023 Jan; 48(1):e12-e15. PubMed ID: 36240803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 68 Ga-DOTATATE and 68 Ga-FAPI Imaging in Neuroendocrine Neoplasms of Different Grades.
    Zhou Y; Ou L; Yu S; Deng H; Chen X
    Clin Nucl Med; 2024 Jun; 49(6):564-566. PubMed ID: 38557828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic Perivascular Epithelioid Cell Tumor Revealed by 68 Ga-DOTATATE PET/CT.
    Sun R; Zeng G; Chen X
    Clin Nucl Med; 2023 Jun; 48(6):515-517. PubMed ID: 37075259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.